Form DEFA14A ORTHOPEDIATRICS CORP
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. __)
Filed by the Registrant | x | ||||
Filed by a Party other than the Registrant | ¨ | ||||
Check the appropriate box: | |||||
¨ | Preliminary Proxy Statement | ||||
¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||||
¨ | Definitive Proxy Statement | ||||
x | Definitive Additional Materials | ||||
¨ | Soliciting Material under §240.14a-12 | ||||
ORTHOPEDIATRICS CORP.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement if other than Registrant)
Payment of Filing Fee (Check the appropriate box): | ||||||||
x | No fee required. | |||||||
¨ | Fee paid previously with preliminary materials. | |||||||
¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||||||






Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OrthoPediatrics signs deal to distribute metal-free bone implants
- NHOA Energy Awarded Culcairn Battery Contract by Neoen in Australia
- NCR Atleos Extends Long-Standing Relationship with Shell UK Oil Products to Operate ATMs Across National Forecourt Network
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share